Global Surgical Robotic Systems Market to Expand at a CAGR of 13.21% Through 2032, Fueled by Technological Breakthroughs and Surge in Minimally Invasive Procedures | DelveInsight

The surgical robotic systems market is witnessing a dynamic shift, driven by the increasing demand for precision, control, and minimally invasive surgical solutions. With a remarkable expansion expected through 2032, the market is poised for substantial expansion as both developed and emerging healthcare systems accelerate the adoption of robotic-assisted surgical technologies.

Surgical robotic platforms are being increasingly used across a wide spectrum of procedures, including urology, gynecology, orthopedics, general surgery, and cardiothoracic surgeries. The rising procedural volume and a strong preference for minimally invasive techniques-due to reduced hospital stays, less post-operative pain, and faster recovery-are major catalysts in the market's upward trajectory.

The market landscape includes advanced systems such as multi-arm robotic platforms, robotic navigation tools, and single-port systems, offering surgeons enhanced dexterity, 3D visualization, and real-time data integration. Notably, innovations such as AI-powered robotics, haptic feedback, cloud-based surgical planning, and machine learning for intraoperative decision-making are redefining the future of robotic surgery.

DelveInsight's Surgical Robotic Systems Market Insights, Competitive Landscape, and Market Forecast - 2032 provides an in-depth analysis of the evolving market dynamics across key regions, including the US, EU4 (Germany, France, Italy, Spain), the UK, Japan, and others. The report features detailed segmentation by surgical specialty, healthcare setting, and system components, alongside insights into reimbursement scenarios, regulatory frameworks, and cost-effectiveness analyses.

Leading players like Intuitive Surgical Inc., Stryker, Johnson & Johnson Services, Inc., Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, and others are aggressively investing in R&D, strategic partnerships, and global expansion to strengthen their foothold. As AI and robotics converge, the surgical robotics market is moving toward an era of greater personalization, precision, and patient safety, signaling a transformative phase for modern surgery.

Explore the latest trends and growth drivers in the surgical robotic system market-download your sample report now https://www.delveinsight.com/report-store/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Key Takeaways from the Surgical Robotic System Market Report
• The global surgical robotic systems market was valued at USD 11,082.32 million in 2024 and is projected to grow at a CAGR of 13.21% from 2025 to 2032, reaching USD 29,785.13 million by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global Surgical Robotic System market during the forecast period.
• Notable Surgical Robotic System companies such as Intuitive Surgical Inc., Stryker, Johnson & Johnson Services, Inc., Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, Medrobotics Corp., Asensus Surgical US, Inc., Globus Medical, Microport Scientific Corporation, Smith & Nephew plc., Accuray Incorporated, THINK Surgical, Renishaw plc., Zimmer Biomet, Siemens Healthineers, Preceyes BV, MicroSure, Memic Innovative Surgery Ltd., and several others are currently operating in the Surgical Robotic System market.
• In May 2025, SS Innovations International (Nasdaq: SSII) announced plans to submit a De Novo Classification Request to the FDA in July for its SSi Mantra 3 surgical robotic system, aimed at making robotic surgery more affordable and globally accessible.
• In April 2025, Medtronic announced that its Expand URO Investigational Device Exemption (IDE) clinical study, the largest of its kind for robotic-assisted urologic surgery, met both primary safety and effectiveness endpoints. The multi-center, single-arm study involved 137 patients who underwent urologic procedures using the HugoTM robotic-assisted surgery (RAS) system.
• In May 2025, SS Innovations International, Inc., a developer of surgical robotic technologies, announced plans to submit a De Novo classification request to the U.S. Food and Drug Administration (FDA) for its SSi Mantra 3 surgical robotic system in July 2025. With a current market valuation of $1.96 billion, the company experienced a 190% increase in its stock price over the past six months, according to data from InvestingPro. If approved, the De Novo request would allow SS Innovations to market the SSi Mantra 3 system in the United States.
• In April 2025, Intuitive (Nasdaq: ISRG) announced FDA clearance of its SP SureForm 45 stapler for use with the da Vinci SP system in thoracic, colorectal, and urologic surgeries.

To read more about the latest highlights related to the surgical robotic system market, get a snapshot of the key highlights entailed in the global surgical robotic system market report here https://www.delveinsight.com/report-store/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Surgical Robotic System Overview
Surgical robotic systems are advanced medical technologies designed to assist surgeons in performing complex procedures with enhanced precision, control, and flexibility through minimally invasive techniques. These systems typically consist of robotic arms, high-definition 3D cameras, and a console where the surgeon operates. By translating the surgeon's hand movements into smaller, more precise actions, surgical robots enable reduced blood loss, smaller incisions, shorter recovery times, and improved patient outcomes. Widely used in urology, gynecology, orthopedics, and general surgery, these systems are revolutionizing surgical care by combining robotics with real-time imaging, artificial intelligence, and data analytics to optimize surgical efficiency and safety.

Surgical Robotic System Market Insights
North America is expected to dominate the surgical robotic systems market in 2024, fueled by a high volume of surgical procedures, rising chronic disease prevalence-especially cancer and orthopedic conditions-and robust product innovation. The region benefits from advanced healthcare infrastructure, strong reimbursement frameworks, and the active presence of key players like Johnson & Johnson, Stryker, Medtronic, and Zimmer Biomet.

According to the American Academy of Orthopaedic Surgeons, the U.S. performed over 100,000 shoulder replacement surgeries in 2021, with projections of up to 350,000 by 2025. In such cases, robot-assisted surgical systems offer enhanced visualization, precise implant placement, and reduced soft tissue damage, making them integral to modern orthopedic procedures.

Moreover, regulatory advancements are propelling growth. For instance, in November 2024, Johnson & Johnson MedTech received FDA Investigational Device Exemption (IDE) approval for its OTTAVATM robotic surgical system, marking a major step in expanding clinical adoption. With continuous technological progress and expanding applications across specialties, robotic-assisted surgeries in North America are set for sustained growth through 2032.

To know more about why North America is leading the market growth in the surgical robotic system market, get a snapshot of the surgical robotic system market outlook here https://www.delveinsight.com/report-store/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Surgical Robotic System Market Dynamics
The global surgical robotic systems market is witnessing robust growth, driven by rising surgical volumes, technological advancements, and increasing adoption across various specialties, including cardiac, orthopedic, urology, and oncology. According to the British Heart Foundation (2024), over 200 million people globally are living with coronary artery disease (CAD), and more than one million cardiac surgeries are performed annually. Robotic systems offer enhanced precision and control in complex cardiovascular procedures like valve repair and bypass surgery, contributing to improved outcomes and faster recovery.

The demand is further amplified by a growing aging population and higher prevalence of chronic diseases. OECD data (2023) highlights high rates of orthopedic surgeries-172 hip and 119 knee replacements per 100,000 people in countries like Germany and Switzerland, indicating increasing surgical needs. Hospitals are investing in robotic platforms to improve efficiency and patient satisfaction. Regulatory milestones, such as CMR Surgical's FDA approval for its Versius system in 2024, are also accelerating market penetration.

However, high capital and maintenance costs, especially in low- and middle-income countries, and the availability of conventional surgical alternatives remain key barriers to widespread adoption. Despite these hurdles, the market is poised for significant expansion through 2032, with a projected CAGR of 13.21%.

Get a sneak peek at the surgical robotic system market dynamics @ https://www.delveinsight.com/report-store/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Coverage: Global
Study Period: 2022 to 2032
Surgical Robotic System Market CAGR: ~13.21%
Key Surgical Robotic System Companies: Intuitive Surgical Inc., Stryker, Johnson & Johnson Services, Inc., Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, Medrobotics Corp., Asensus Surgical US, Inc., Globus Medical, Microport Scientific Corporation, Smith & Nephew plc., Accuray Incorporated, THINK Surgical, Renishaw plc., Zimmer Biomet, Siemens Healthineers, Preceyes BV, MicroSure, Memic Innovative Surgery Ltd., and others.

Surgical Robotic System Market Segmentation
Market Segmentation By Component: System, Instruments & Accessories, and Services.
Market Segmentation By Application: Urology, Gynecology, Neurosurgery, Orthopedics, and others.
Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World

Which MedTech key players in the surgical robotic system market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/surgical-robotic-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Table of Contents
1. Surgical Robotic System Market Report Introduction
2. Surgical Robotic System Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Surgical Robotic System Market Key Factors Analysis
6. Surgical Robotic System Market Porter's Five Forces Analysis
7. Surgical Robotic System Market Layout
8. Surgical Robotic System Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.